Aberer, F.; Hochfellner, D.A.; Baumann, P.M.; Höll, B.; Beck, P.; Pieber, T.R.; Mader, J.K.
Glycemic Efficacy and Safety by Using Insulin Degludec and Aspart Guided by a Clinical Decision Support System in Non-Critically Ill Inpatients with Type 2 Diabetes Mellitus. Biosensors 2026, 16, 289.
https://doi.org/10.3390/bios16050289
AMA Style
Aberer F, Hochfellner DA, Baumann PM, Höll B, Beck P, Pieber TR, Mader JK.
Glycemic Efficacy and Safety by Using Insulin Degludec and Aspart Guided by a Clinical Decision Support System in Non-Critically Ill Inpatients with Type 2 Diabetes Mellitus. Biosensors. 2026; 16(5):289.
https://doi.org/10.3390/bios16050289
Chicago/Turabian Style
Aberer, Felix, Daniel A. Hochfellner, Petra M. Baumann, Bernhard Höll, Peter Beck, Thomas R. Pieber, and Julia K. Mader.
2026. "Glycemic Efficacy and Safety by Using Insulin Degludec and Aspart Guided by a Clinical Decision Support System in Non-Critically Ill Inpatients with Type 2 Diabetes Mellitus" Biosensors 16, no. 5: 289.
https://doi.org/10.3390/bios16050289
APA Style
Aberer, F., Hochfellner, D. A., Baumann, P. M., Höll, B., Beck, P., Pieber, T. R., & Mader, J. K.
(2026). Glycemic Efficacy and Safety by Using Insulin Degludec and Aspart Guided by a Clinical Decision Support System in Non-Critically Ill Inpatients with Type 2 Diabetes Mellitus. Biosensors, 16(5), 289.
https://doi.org/10.3390/bios16050289
